PVI
TNGX icon

Pura Vida Investments’s Tango Therapeutics TNGX Stock Holding History

Pura Vida Investments’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-82,727
Closed -$627K – 276
2022
Q1 		$627K Buy
82,727
+500
+0.6% +$4.33K 0.02% 195
2021
Q4 		$900K Sell
82,227
-2,535
-3% -$30.5K 0.03% 187
2021
Q3 		$1.1M Sell
84,762
-14,159
-14% -$170K 0.03% 216
2021
Q2 		$1.13M Buy
+98,921
New +$1.11M 0.04% 174

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Pura Vida Investments's TNGX Position: Q2 2022 in Review

Pura Vida Investments sold out of Tango Therapeutics (TNGX) in Q2 2022, closing a stake of 82,727 shares — an estimated $627K sold.

Pura Vida Investments first reported a position in TNGX in Q2 2021 and held it in 4 quarters. The position peaked at $1.13M in Q2 2021. 77 funds tracked by Wall St. Rank hold TNGX as of Q2 2022.

  • Pura Vida Investments reported no remaining Tango Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 82,727 Tango Therapeutics shares in Q2 2022, an estimated $627K.
  • Pura Vida Investments first reported a position in Tango Therapeutics in Q2 2021 and held it in 4 quarters.
  • Pura Vida Investments's Tango Therapeutics position peaked at $1.13M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.